FDA Warning Letter: Amazon.com, Inc.
type: Action
additional type: https://schema.org/RegulationAction
start time: 2023-11-14
description: Unapproved New Drugs/Misbranded. Issued by FDA Center for Drug Evaluation and Research | CDER on 2023-11-13.
agent: FDA Center for Drug Evaluation and Research | CDER
object: Amazon.com, Inc.
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
source organization: U.S. Food and Drug Administration
publisher: AI Analytics

PropertyValue
property ID: FDA Warning Letter ID
value: 0046d5ebe67908f3

AI Analytics
type: Organization